John Dumot is a Gastroenterology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 286 publications with 7,275 citations (h-index 48); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
Sponsor: Case Comprehensive Cancer Center
- Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Sponsor: Case Western Reserve University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
77.4%Proton pump inhibitor35.2%Omeprazole43%Pantoprazole Sodium35%Esomeprazole Magnesium13%Lansoprazole8%Part D<11 patientsAntidiarrheal microorganisms8.6%Creon100%Part D≥26 patients+ 13 more classes in this area
Cardiovascular
10.5%Bile Acid Sequestrant5.2%Colestipol Hcl58%Cholestyramine42%Part D≥13 patientsBeta blocker1.6%Carvedilol100%Part D<11 patients+ 3 more classes in this area
Nervous system
10.3%Tricyclic Antidepressant5%Amitriptyline Hcl100%Part D≥20 patientsGabapentinoids1.9%Gabapentin100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Ian Neeland, MD
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”